Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-dependent anion channel 2 pseudogene is a DNA sequence resembling the functional VDAC2 gene but is typically not transcribed into a functional protein and is generally classified as noncoding. While VDAC2 is an essential outer mitochondrial membrane protein involved in ion transport, metabolism, and apoptosis[1][3], its pseudogenes—such as those annotated on chromosomes 1, 2, 12, and 21—do not produce active proteins and lack established roles in physiology or disease. Current evidence indicates that VDAC2 pseudogenes are not expressed at biologically relevant levels[8]. Unlike some other pseudogenes that can regulate functional gene expression via RNA-based mechanisms (e.g., acting as competing endogenous RNAs, or ceRNAs), there is no well-characterized role or therapeutic relevance attributed to VDAC2 pseudogenes.
None; not a protein, not targeted by any drug
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent anion channel 2 pseudogene (VDAC2 pseudogene).